Latest Administration News

Noxopharm has initiated its HERACLES clinical trial for SOF-SKN, marking a key milestone for its Sofra platform, while deepening partnerships and actively seeking new funding to sustain development.

Mineral Resources Limited has met its FY25 production and cost guidance across all segments, boosted by a cashflow-positive Onslow Iron joint venture and record low costs at Wodgina. The company also strengthened its board and initiated a governance review.

Coda Minerals reports breakthrough metallurgical results at its Elizabeth Creek Copper-Cobalt Project, achieving copper recoveries up to 95.9% and advancing key environmental approvals.

Spectur Limited reports a positive operating cash flow for Q4 FY25, driven by revenue growth and cost-cutting, alongside strategic investments in cloud and connectivity technology.

Spectur Limited reported a solid quarter ending June 2025, posting positive net operating cash flow and increasing its cash reserves to over $1 million. The company maintained steady financing arrangements while managing operating costs effectively.

Triangle Energy’s June quarter report reveals a strategic pivot as key JV partners exit, the Cliff Head assets transition to carbon capture, and promising exploration prospects remain in focus.

MetalsTech Limited has raised A$3.3 million through strategic placements to fund the advancement of its Sturec Gold Mine Pre-Feasibility Study, which shows strong economic potential with a US$768 million NPV. The company is progressing metallurgical testing and ore sorting technology to enhance project value.

Axiom Properties Limited reported a $1.67 million increase in cash reserves this quarter, driven by strong performance from its PaySure business and completion of the Mt Barker Glenlea Estate project.

Tyranna Resources has completed initial steps to acquire a majority interest in Angola’s Maongo Copper-Gold Project, complementing ongoing lithium exploration at Namibe. The company is poised to restart mining activities dormant since the 1960s, backed by a solid cash position and strategic regional assets.

BWP Property Group and BWP Trust have launched a new Distribution Reinvestment Plan allowing stapled securityholders to reinvest cash distributions into additional securities, potentially at a discount and without transaction costs.

Chimeric Therapeutics has advanced its CHM CDH17 CAR-T program with dose escalation and FDA Fast Track status, alongside promising early results in AML trials and a successful $6.6 million capital raise.

Epsilon Healthcare has completed a $6.7 million sale and leaseback of its Southport manufacturing site, significantly reducing debt and securing long-term operational stability.